Literature DB >> 8636852

The inflammatory response promotes cutaneous metastasis in hamsters infected with Leishmania (Viannia) panamensis.

B L Travi1, Y Osorio, N G Saravia.   

Abstract

The influence of nonspecific and immunologically elicited inflammatory responses on the development of metastatic lesions was examined in the hamster model of Leishmania (Viannia) panamensis infection. Delayed type hypersensitivity (DTH) responses were induced using the contact sensitizing agent DNFB (2, 4-dinitro-1-fluorobenzene) and infection with L. panamensis followed by intradermal application of leishmanin. Nonspecific inflammatory response was achieved by the surgical excision of toes. The inductive and eliciting procedures were performed on the ears and fore and hind paws of the right side of experimental groups of hamsters that were inoculated in the snout with a highly metastatic strain of L. panamensis (MHOM/COL/84/1099). Skin metastases were detected by physical evaluation at 15-day intervals over a period of 7-8 mo. Suspected metastases were parasitologically confirmed by culture of tissue fluid aspirated from the lesion. The frequency of metastatic lesions was greater in hamsters subjected to inflammatory stimuli (14/38) than control animals (6/33; P = 0.035). Likewise, the frequency of metastases at the site of induction and elicitation of inflammation (18/22 lesions) in the experimental groups was greater than that observed at the same site in control animals (5/11 lesions; P = 0.017). These findings support a causal relationship between inflammatory response and the development of lesions in this model of secondary disease caused by L. panamensis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8636852

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  10 in total

1.  Chronicity of dermal leishmaniasis caused by Leishmania panamensis is associated with parasite-mediated induction of chemokine gene expression.

Authors:  Adriana Navas; Deninson Alejandro Vargas; Marina Freudzon; Diane McMahon-Pratt; Nancy Gore Saravia; María Adelaida Gómez
Journal:  Infect Immun       Date:  2014-04-21       Impact factor: 3.441

2.  T-bet, GATA-3, and Foxp3 expression and Th1/Th2 cytokine production in the clinical outcome of human infection with Leishmania (Viannia) species.

Authors:  Yira Rosalba Díaz; Ricardo Rojas; Liliana Valderrama; Nancy Gore Saravia
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

3.  Muco-cutaneous leishmaniasis in the New World: the ultimate subversion.

Authors:  Catherine Ronet; Stephen M Beverley; Nicolas Fasel
Journal:  Virulence       Date:  2011-11-01       Impact factor: 5.882

4.  Cutaneous leishmaniasis in the dorsal skin of hamsters: a useful model for the screening of antileishmanial drugs.

Authors:  Sara M Robledo; Lina M Carrillo; Alejandro Daza; Adriana M Restrepo; Diana L Muñoz; Jairo Tobón; Javier D Murillo; Anderson López; Carolina Ríos; Carol V Mesa; Yulieth A Upegui; Alejandro Valencia-Tobón; Karina Mondragón-Shem; Berardo Rodríguez; Iván D Vélez
Journal:  J Vis Exp       Date:  2012-04-21       Impact factor: 1.355

5.  Duplex real-time reverse transcriptase PCR to determine cytokine mRNA expression in a hamster model of New World cutaneous leishmaniasis.

Authors:  Claudia M Espitia; Weiguo Zhao; Omar Saldarriaga; Yaneth Osorio; Lisa M Harrison; Michael Cappello; Bruno L Travi; Peter C Melby
Journal:  BMC Immunol       Date:  2010-06-22       Impact factor: 3.615

6.  TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia).

Authors:  Asha Jayakumar; Tiago M Castilho; Esther Park; Karen Goldsmith-Pestana; Jenefer M Blackwell; Diane McMahon-Pratt
Journal:  PLoS Negl Trop Dis       Date:  2011-06-14

7.  Proteins of Leishmania (Viannia) shawi confer protection associated with Th1 immune response and memory generation.

Authors:  Luiz Felipe D Passero; Ana Kely Carvalho; Maria Lac Bordon; Alexis Bonfim-Melo; Karina Carvalho; Esper G Kallás; Bianca Ba Santos; Marcos H Toyama; Adriana Paes-Leme; Carlos Ep Corbett; Márcia D Laurenti
Journal:  Parasit Vectors       Date:  2012-03-30       Impact factor: 3.876

8.  Transcriptional profiling of the spleen in progressive visceral leishmaniasis reveals mixed expression of type 1 and type 2 cytokine-responsive genes.

Authors:  Claudia M Espitia; Omar A Saldarriaga; Bruno L Travi; E Yaneth Osorio; Alvaro Hernandez; Mark Band; Mandakini J Patel; Audrie A Medina; Michael Cappello; Andrew Pekosz; Peter C Melby
Journal:  BMC Immunol       Date:  2014-11-26       Impact factor: 3.615

Review 9.  Leishmania RNA virus: when the host pays the toll.

Authors:  Mary-Anne Hartley; Catherine Ronet; Haroun Zangger; Stephen M Beverley; Nicolas Fasel
Journal:  Front Cell Infect Microbiol       Date:  2012-07-12       Impact factor: 5.293

10.  Immune Profile of the Nasal Mucosa in Patients with Cutaneous Leishmaniasis.

Authors:  María J Gómez-Zafra; Adriana Navas; Jimena Jojoa; Julieth Murillo; Camila González; María Adelaida Gómez
Journal:  Infect Immun       Date:  2020-04-20       Impact factor: 3.609

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.